scholarly article | Q13442814 |
P356 | DOI | 10.4155/FMC.12.123 |
P953 | full work available at URL | https://www.tandfonline.com/doi/pdf/10.4155/fmc.12.123 |
P698 | PubMed publication ID | 22924500 |
P50 | author | Gregory D Cuny | Q90950592 |
P2860 | cites work | Current Understanding Of LRRK2 In Parkinson’s Disease: Biochemical And Structural Features And Inhibitor Design | Q26827527 |
Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases | Q34296136 | ||
Therapeutic strategies for the treatment of spinal muscular atrophy. | Q34296140 | ||
Small-molecule Klotho enhancers as novel treatment of neurodegeneration | Q34394061 | ||
Natural Products As A Rich Source Of Tau-Targeting Drugs For Alzheimer’s Disease | Q36617889 | ||
Modulating Macroautophagy: A Neuronal Perspective | Q38038228 | ||
An alternative approach to drug discovery for Alzheimer's disease dementia | Q39563068 | ||
The future of neurodegenerative diseases: emerging targets, treatments and technologies | Q48414266 | ||
Targeting the cellular prion protein to treat neurodegeneration. | Q51563560 | ||
Modeling Neurodegenerative Diseases Using Stem Cells: Is It Accelerating Drug Discovery? | Q51563569 | ||
P433 | issue | 13 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neurodegeneration | Q1755122 |
P304 | page(s) | 1647-1649 | |
P577 | publication date | 2012-09-01 | |
P1433 | published in | Future Medicinal Chemistry | Q19280078 |
P1476 | title | Foreword: neurodegenerative diseases: challenges and opportunities | |
Neurodegenerative Diseases: Challenges And Opportunities | |||
P478 | volume | 4 |
Q57169512 | Current Screening Methodologies in Drug Discovery for Selected Human Diseases |
Q31002975 | Genetically modified pig models for neurodegenerative disorders |
Q38242113 | Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases |
Q90457655 | Misfolded Protein Linked Strategies Toward Biomarker Development for Neurodegenerative Diseases |
Q98945316 | Potential Impact of the Multi-Target Drug Approach in the Treatment of Some Complex Diseases |
Q38182492 | Prediction of the repeat domain structures and impact of parkinsonism-associated variations on structure and function of all functional domains of leucine-rich repeat kinase 2 (LRRK2). |
Search more.